Renaissance Technologies
XTNT icon

Renaissance Technologies’s Xtant Medical Holdings XTNT Stock Holding History

Renaissance Technologies’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$551K Buy
987,410
+67,550
+7% +$41.6K ﹤0.01% 2562
2025
Q4 		$721K Buy
919,860
+205,945
+29% +$150K ﹤0.01% 2425
2025
Q3 		$463K Buy
713,915
+63,205
+10% +$39.9K ﹤0.01% 2831
2025
Q2 		$481K Sell
650,710
-60,500
-9% -$34.4K ﹤0.01% 2848
2025
Q1 		$334K Sell
711,210
-86,823
-11% -$45.7K ﹤0.01% 2892
2024
Q4 		$354K Buy
798,033
+103,825
+15% +$50.3K ﹤0.01% 2988
2024
Q3 		$469K Sell
694,208
-9,602
-1% -$6.35K ﹤0.01% 2820
2024
Q2 		$443K Sell
703,810
-59,500
-8% -$47.5K ﹤0.01% 2748
2024
Q1 		$893K Buy
763,310
+22,400
+3% +$24.6K ﹤0.01% 2554
2023
Q4 		$837K Buy
740,910
+71,172
+11% +$83.7K ﹤0.01% 2523
2023
Q3 		$737K Buy
669,738
+72,728
+12% +$78K ﹤0.01% 2504
2023
Q2 		$555K Sell
597,010
-5,800
-1% -$3.87K ﹤0.01% 2820
2023
Q1 		$384K Sell
602,810
-3,500
-0.6% -$2.56K ﹤0.01% 3008
2022
Q4 		$400K Sell
606,310
-20,900
-3% -$13.7K ﹤0.01% 3082
2022
Q3 		$451K Sell
627,210
-43,690
-7% -$23.9K ﹤0.01% 2983
2022
Q2 		$349K Buy
670,900
+4,700
+0.7% +$2.78K ﹤0.01% 3367
2022
Q1 		$453K Sell
666,200
-55,400
-8% -$36.3K ﹤0.01% 3257
2021
Q4 		$404K Buy
721,600
+40,800
+6% +$38.4K ﹤0.01% 3184
2021
Q3 		$756K Sell
680,800
-331,200
-33% -$431K ﹤0.01% 2698
2021
Q2 		$1.65M Buy
1,012,000
+90,229
+10% +$160K ﹤0.01% 2387
2021
Q1 		$2.17M Buy
921,771
+294,081
+47% +$628K ﹤0.01% 2169
2020
Q4 		$751K Buy
627,690
+251,002
+67% +$323K ﹤0.01% 2637
2020
Q3 		$310K Buy
376,688
+152,000
+68% +$149K ﹤0.01% 2981
2020
Q2 		$202K Buy
224,688
+135,927
+153% +$125K ﹤0.01% 3157
2020
Q1 		$59K Buy
88,761
+4,700
+6% +$5.67K ﹤0.01% 3301
2019
Q4 		$134K Buy
84,061
+3,300
+4% +$6.77K ﹤0.01% 3263
2019
Q3 		$229K Buy
80,761
+6,100
+8% +$16.9K ﹤0.01% 3108
2019
Q2 		$224K Buy
74,661
+7,500
+11% +$23.1K ﹤0.01% 3275
2019
Q1 		$205K Buy
67,161
+11,113
+20% +$32.4K ﹤0.01% 3206
2018
Q4 		$90K Buy
56,048
+5,700
+11% +$18.4K ﹤0.01% 3242
2018
Q3 		$194K Buy
50,348
+6,700
+15% +$35.4K ﹤0.01% 3160
2018
Q2 		$242K Buy
43,648
+3,400
+8% +$22.7K ﹤0.01% 3031
2018
Q1 		$318K Buy
40,248
+15,924
+65% +$105K ﹤0.01% 3061
2017
Q4 		$167K Buy
24,324
+14,425
+146% +$114K ﹤0.01% 3164
2017
Q3 		$86K Buy
+9,899
New +$88.5K ﹤0.01% 3094
2017
Q1 		– Sell
-5,542
Closed -$37K – 3439
2016
Q4 		$37K Buy
5,542
+3,734
+207% +$32.2K ﹤0.01% 3184
2016
Q3 		$25K Buy
+1,808
New +$33.3K ﹤0.01% 3286
2015
Q2 		– Sell
-1,342
Closed -$66K – 3415
2015
Q1 		$66K Buy
+1,342
New +$54K ﹤0.01% 3055
2014
Q1 		– Sell
-534
Closed -$32K – 3042
2013
Q4 		$32K Buy
534
+406
+317% +$25.9K ﹤0.01% 2802
2013
Q3 		$10K Buy
+128
New +$9.19K ﹤0.01% 2779

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies's XTNT Position: Q1 2026 in Review

Renaissance Technologies increased its Xtant Medical Holdings (XTNT) stake by 7.3% in Q1 2026, buying an estimated $41.6K and bringing the position to 987,410 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

Renaissance Technologies first reported a position in XTNT in Q3 2013 and has held it in 40 quarters since. The position peaked at $2.17M in Q1 2021. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

  • Renaissance Technologies held 987,410 shares of Xtant Medical Holdings worth $551K as of Q1 2026.
  • Renaissance Technologies bought 67,550 Xtant Medical Holdings shares in Q1 2026, an estimated $41.6K.
  • Xtant Medical Holdings made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2562 holding.
  • Renaissance Technologies first reported a position in Xtant Medical Holdings in Q3 2013 and has held it in 40 quarters since.
  • Renaissance Technologies's Xtant Medical Holdings position peaked at $2.17M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.